Amsterdam Area, Netherlands, March 2026 – Axplora has appointed David Gonzalez as President Commercial – Specialty Products Business Unit, reinforcing its commercial leadership as the company continues to expand its global footprint in API manufacturing and CDMO solutions.
In his new role, David will lead commercial strategy, global sales, market expansion, and customer partnerships for the Specialty Products Business Unit, supporting Axplora’s mission to deliver high-quality pharmaceutical ingredients and accelerate innovation for global healthcare.
David Gonzalez brings extensive global commercial leadership experience across the pharmaceutical and API industry. Most recently, he served as Chief Marketing Officer at Granules India Limited, where he drove global marketing strategy and commercial growth across key markets.
Prior to that, he was Head of Commercial API at Polpharma, leading commercial operations and strengthening market presence in the active pharmaceutical ingredients segment.
He also held senior leadership roles at Glenmark Pharmaceuticals, including Chief Commercial Officer at Glenmark Life Sciences and Group Vice President & Global Head API, where he led global commercial strategy and business expansion.
Earlier in his career, David spent over seven years at TAPI – Teva Active Pharmaceutical Ingredients, holding multiple leadership roles including Senior Sales Director for Europe, India & SEA, Head of Sales TAPI International, and Sales Director – General Manager, managing large-scale international markets and driving significant revenue growth.
He began his professional journey with roles at Farmhispania Group and Teva Pharmaceuticals, building strong expertise in API sales, global markets, and business development.
David also co-founded DG Solutions, reflecting his entrepreneurial mindset and strategic advisory capabilities.
He holds an MBA from IE Business School, further strengthening his global business and leadership perspective.
About Axplora
Axplora is a leading API manufacturing and CDMO partner formed by bringing together Farmabios, Novasep, and PharmaZell.
The company supports global pharmaceutical and biotechnology organizations by delivering high-quality active ingredients at scale, with a strong focus on reliability, sustainability, and innovation.
With nine industrial sites across Europe and India, an R&D facility in the United States, and a workforce of over 2,400 employees globally, Axplora plays a critical role in advancing the development of medicines for patients worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
Click Here to Join HR TODAY WhatsApp Channel









